Generalised linear mixed analysis of independent variables associated with the number of microembolic signals in patients with mechanical heart valves
Multivariable analysis | ||||
Characteristics | Preoxygenation phase | Postoxygenation phase | ||
OR (95% CI) | P value | OR (95% CI) | P value | |
Age | 0.88 (0.82 to 0.93) | 0.000 | 0.92 (0.87 to 0.98) | 0.008 |
Female | 0.37 (0.10 to 1.38) | 0.14 | 1.19 (0.29 to 4.88) | 0.80 |
Currently smoking | 4.62 (1.79 to 11.93) | 0.002 | 8.53 (1.03 to 70.55) | 0.04 |
Atrial fibrillation | 0.54 (0.25 to 1.16) | 0.11 | 0.69 (0.30 to 1.60) | 0.37 |
Warfarin and aspirin | 2.57 (0.75 to 8.88) | 0.13 | 3.80 (1.50 to 9.66) | 0.007 |
Operation to monitoring period | 1.01 (1.00 to 1.01) | 0.01 | 1.01 (1.007 to 1.015) | 0.00 |
Location of valve replacement | ||||
Mitral location* | 0.06 (0.01 to 0.33) | 0.002 | 0.11 (0.005 to 2.30) | 0.14 |
>1 Mechanical valve* | 3.63 (1.27 to 10.41) | 0.017 | 2.72 (0.51 to 13.90) | 0.22 |
INR | 1.07 (0.76 to 1.50) | 0.70 | 0.75 (0.57 to 1.00) | 0.05 |
tHcy | 1.34 (1.07 to 1.68) | 0.009 | 1.40 (1.07 to 1.83) | 0.01 |
Reference group: *aorta.
INR, international normalised ratio; tHcy, total homocysteine.